Elizabeth L Addington1, Elaine O Cheung2, Sarah M Bassett2, Ian Kwok2, Stephanie A Schuette3, Eva Shiu2, Dershung Yang4, Michael A Cohn5, Yan Leykin6, Laura R Saslow7, Judith T Moskowitz2. 1. Department of Medical Social Sciences, Osher Center for Integrative Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. Electronic address: elizabeth.addington@northwestern.edu. 2. Department of Medical Social Sciences, Osher Center for Integrative Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. 3. Department of Psychology and Neuroscience, Duke University, Durham, NC, USA. 4. BrightOutcome, Inc, USA. 5. Osher Center for Integrative Medicine, University of California, San Francisco, San Francisco, CA, USA. 6. Palo Alto University, Palo Alto, CA, USA. 7. Department of Health Behavior and Biological Sciences, School of Nursing, University of Michigan, Ann Arbor, MI, USA.
Abstract
BACKGROUND: This manuscript describes the first two phases of pilot testing MARIGOLD, an online self-guided positive emotion skills intervention for adults with elevated depressive symptoms, along with enhancements to overcome retention and adherence problems reported in previous research. METHODS:Adults with elevated depressive symptoms were recruited online and assessed at baseline, post-intervention, 1- and 3-month follow-up. Phase 1 participants (n = 58) were randomized to MARIGOLD, daily emotion reporting, or waitlist. Phase 2 participants (n = 79) were randomized to MARIGOLD plus one enhancement: online discussion board (ODB), virtual badges (VB), or facilitator contact (FC). Post-intervention interviews assessed acceptability. Intention-to-treat analyses examined retention, adherence, and preliminary efficacy. RESULTS: In both phases, retention and adherence did not differ between groups. MARIGOLD skills were highly acceptable, but qualitative results indicate web-based features (e.g., log-in, ODB, VB) require refinement prior to larger testing. Neither phase demonstrated between-group differences in preliminary efficacy. In Phase 1 within-group analyses, MARIGOLD and emotion reporting control demonstrated a similar pattern of findings (stable depressive symptoms, increased positive emotion, decreased negative emotion and stress), whereas the waitlist group significantly increased in depressive mood. Most Phase 2 within-group analyses demonstrated the expected pattern of results (i.e., decreases in PHQ-8 and negative emotion, increases in positive emotion). However, CES-D scores were stable in FC; perceived stress was stable in FC and ODB. LIMITATIONS: This pilot study is not powered to evaluate efficacy. CONCLUSION:Positive emotion skills, plus enhancements for web-based, self-guided delivery, warrant additional study in people with elevated depressive symptoms.
RCT Entities:
BACKGROUND: This manuscript describes the first two phases of pilot testing MARIGOLD, an online self-guided positive emotion skills intervention for adults with elevated depressive symptoms, along with enhancements to overcome retention and adherence problems reported in previous research. METHODS: Adults with elevated depressive symptoms were recruited online and assessed at baseline, post-intervention, 1- and 3-month follow-up. Phase 1 participants (n = 58) were randomized to MARIGOLD, daily emotion reporting, or waitlist. Phase 2 participants (n = 79) were randomized to MARIGOLD plus one enhancement: online discussion board (ODB), virtual badges (VB), or facilitator contact (FC). Post-intervention interviews assessed acceptability. Intention-to-treat analyses examined retention, adherence, and preliminary efficacy. RESULTS: In both phases, retention and adherence did not differ between groups. MARIGOLD skills were highly acceptable, but qualitative results indicate web-based features (e.g., log-in, ODB, VB) require refinement prior to larger testing. Neither phase demonstrated between-group differences in preliminary efficacy. In Phase 1 within-group analyses, MARIGOLD and emotion reporting control demonstrated a similar pattern of findings (stable depressive symptoms, increased positive emotion, decreased negative emotion and stress), whereas the waitlist group significantly increased in depressive mood. Most Phase 2 within-group analyses demonstrated the expected pattern of results (i.e., decreases in PHQ-8 and negative emotion, increases in positive emotion). However, CES-D scores were stable in FC; perceived stress was stable in FC and ODB. LIMITATIONS: This pilot study is not powered to evaluate efficacy. CONCLUSION: Positive emotion skills, plus enhancements for web-based, self-guided delivery, warrant additional study in people with elevated depressive symptoms.
Authors: Robert D Goldney; Laura J Fisher; Eleonora Dal Grande; Anne W Taylor Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2004-04 Impact factor: 4.328
Authors: Robert M Bossarte; Ronald C Kessler; Andrew A Nierenberg; Ambarish Chattopadhyay; Pim Cuijpers; Angel Enrique; Phyllis M Foxworth; Sarah M Gildea; Bea Herbeck Belnap; Marc W Haut; Kari B Law; William D Lewis; Howard Liu; Alexander R Luedtke; Wilfred R Pigeon; Larry A Rhodes; Derek Richards; Bruce L Rollman; Nancy A Sampson; Cara M Stokes; John Torous; Tyler D Webb; Jose R Zubizarreta Journal: Trials Date: 2022-06-20 Impact factor: 2.728
Authors: Margalida Gili; Adoración Castro; Azucena García-Palacios; Javier Garcia-Campayo; Fermin Mayoral-Cleries; Cristina Botella; Miquel Roca; Alberto Barceló-Soler; María M Hurtado; MªTeresa Navarro; Amelia Villena; M Ángeles Pérez-Ara; Pau Riera-Serra; Rosa Mª Baños Journal: J Med Internet Res Date: 2020-06-05 Impact factor: 5.428
Authors: Judith Tedlie Moskowitz; Elizabeth L Addington; Eva Shiu; Sarah M Bassett; Stephanie Schuette; Ian Kwok; Melanie E Freedman; Yan Leykin; Laura R Saslow; Michael A Cohn; Elaine O Cheung Journal: J Med Internet Res Date: 2021-09-22 Impact factor: 5.428
Authors: Elaine O Cheung; Ian Kwok; Allison B Ludwig; William Burton; Xinzi Wang; Neha Basti; Elizabeth L Addington; Carly Maletich; Judith T Moskowitz Journal: Glob Adv Health Med Date: 2021-01-28